| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.084 | 0.09 |